- Home
- COYA vs AEI Comparison
COYA vs AEI Comparison
Compare COYA & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COYA | AEI |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building operators |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.6M | 119.4M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | COYA | AEI |
|---|---|---|
| Price | $4.65 | $2.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.80 | N/A |
| AVG Volume (30 Days) | ★ 148.1K | 24.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 93.40 |
| EPS | N/A | ★ N/A |
| Revenue | $3,554,061.00 | ★ $16,238,200.00 |
| Revenue This Year | $70.00 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.94 | $0.70 |
| 52 Week High | $8.29 | $4.55 |
Technical Indicators
Market Signals| Indicator | COYA | AEI |
|---|---|---|
| Relative Strength Index (RSI) | 45.81 | 34.88 |
| Support Level | $4.41 | $1.13 |
| Resistance Level | $6.15 | $3.51 |
| Average True Range (ATR) | 0.28 | 0.31 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 29.67 | 0.01 |
Price Performance
Historical ComparisonAbout COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.